LAS VEGAS--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, will present its clinically proven fish-skin graft ...
Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
IRVINE, Calif.--(BUSINESS WIRE)--Biogennix, an osteobiologics company specializing in products for bone graft procedures, has announced the publication of a detailed scientific study characterizing ...
CHICAGO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Stem Health Plus, a leader in regenerative medicine, is introducing groundbreaking advancements in the field of skin regeneration through its proprietary ...
SurGenTec has gained 510(k) clearance for OsteoFlo HydroFiber, a synthetic material for use in spinal surgery, from the US Food and Drug Administration (FDA). For use in spinal surgery processes ...
Autogenous bone grafting continues to be the most desirable alternative for treatment of a number of common orthopaedic conditions. Autogenous bone graft has the advantage of being accessible during ...
Jan 25 (Reuters) - Medical device company NuVasive Inc. said it acquired bone grafting technology from privately held, California-based Radius Medical LLC for about $16 million in cash and stock. The ...
In a study published in the journal Burns & Trauma, researchers from Shanghai Jiao Tong University and Donghua University developed a new type of vascular graft using 3D printing and electrospinning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback